v3.26.1
Restructuring and Other Impairment Activities (Tables)
 6 Months Ended
Jun. 30, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Total Restructuring, Restructuring Related, and Impairment Expense and Changes in Restructuring Liabilities
The following table summarizes total restructuring and other impairment expense (in millions):
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Filtration and Advanced Materials(1)
Severance and termination benefits$0.1 $1.8 $0.1 $2.1 
Other exit costs0.6 0.4 1.8 0.8 
FAM restructuring expense0.7 2.2 1.9 2.9 
Sustainable and Adhesive Solutions
Severance and termination benefits— 0.2 — 0.4 
Other exit costs— — — 0.1 
SAS restructuring expense— 0.2 — 0.5 
Unallocated
Severance and termination benefits— 1.4 — 1.4 
Unallocated restructuring expense— 1.4 — 1.4 
Total restructuring expense0.7 3.8 1.9 4.8 
Filtration and Advanced Materials
Other impairment expense— — 0.1 5.3 
Total restructuring and other impairment expense$0.7 $3.8 $2.0 $10.1 
(1)Includes costs associated with facility closures initiated in prior years of $0.6 million and $1.8 million for the three months ended June 30, 2026 and 2025, respectively. Through June 30, 2026, the Company has recognized accumulated restructuring and impairment charges of $12.7 million related to an ongoing facility closure. During the remainder of 2026, the Company expects to record additional restructuring costs in the FAM segment, not expected to exceed $1.5 million related to the closure of this facility.

The following table summarizes changes in restructuring liabilities (in millions):
20262025
Balance at beginning of the period
$2.5 $2.2 
Charges for restructuring programs
2.0 4.8 
Cash payments and other
(2.2)(3.1)
Balance at end of the period
$2.3 $3.9